The purpose of the study reported here was to examine in more detail the phenomenon they described.
We offer an alternative postulate for the origin of "CSF procoagulant."
MATERIALS AND METHODS

Substrate Plasmas
All blood samples were collected into plastic syringes and processed entirely with plastic until time of use. Blood was anticoagulated with 3.8% sodium citrate in a ratio of nine parts whole blood to one part anticoagulant unless otherwise specified. 
RESULTS
Effect ofCentrifugation ofSubstrate Plasma
Blood of 20 normal donors was pooled after centrifugation at 500, 4300, or 39000 g. Recalcification times were performed after 3-mm glass activation. The CSF from five children who were completing cranial radiation and intrathecal therapy were substituted for saline (control) and tested using each of the variously centrifuged plasmas as substrate. Table  I summarizes the inability of these "active" CSFs to shorten the recalcification time of ultracentrifuged and filtered plasma.
Correction of Congenitally Deficient Plasmas
PRTs were performed after 3-mm glass activation upon plasmas congenitally deficient in II, VII, VIII, IX, X, XI, and XII and artificial factor-V-deficient plasma substituting active CSFs for saline. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
